Key statistics
52-week range
Open | 0.1655 |
---|---|
High | 0.1655 |
Low | 0.165 |
Bid | 0.165 |
Offer | 0.167 |
Previous close | 0.163 |
Average volume | 1.24m |
---|---|
Shares outstanding | 1.23bn |
Free float | 1.21bn |
P/E (TTM) | -- |
Market cap | 200.09m DKK |
EPS (TTM) | -0.0291 DKK |
Data delayed at least 15 minutes, as of Nov 06 2024 10:51 GMT.
More ▼
- Pharma Equity Group's subsidiary (Reponex Pharmaceuticals A/S) has obtained patent protection in Japan for the treatment of colorectal cancer with RNX-051.
- Pharma Equity Group’s datterselskab (Reponex Pharmaceuticals A/S) har opnået patentbeskyttelse i Japan på behandling af colorectal cancer med RNX-051.
- Storaktionærmeddelelse - Pharma Equity Group A/S
- Major shareholder announcement - Pharma Equity Group A/S
- Ledende medarbejderes transaktioner
- Managers’ transactions
- Pharma Equity Group announces successful completion of directed issue of new shares
- Pharma Equity Group offentliggør succesfuld gennemførsel af rettet emission
- Pharma Equity Group offentliggør udstedelse af nye aktier i en rettet emission
- Pharma Equity Group announces issuance of new shares in a direct issue
More ▼